Shumway Capital
11
45M
5
0.92
1
0.55
1
- Stages of investment
- Areas of investment
Summary
Shumway Capital is the famous VC, which was founded in 2011. The venture was found in North America in United States. The main department of described VC is located in the Greenwich.
Among the most popular portfolio startups of the fund, we may highlight Finch Therapeutics Group, Vedanta Biosciences, Artsy. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Banking, Pharmaceutical. Besides, a startup needs to be aged 11-15 years to get the investment from the fund.
The fund is constantly included in less than 2 deals per year. The real fund results show that this VC is 23 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 10 - 50 millions dollars. The average startup value when the investment from Shumway Capital is 100-500 millions dollars. The high activity for fund was in 2019.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Shumway Capital, startups are often financed by Thrive Capital, ZhenFund, Willett Advisors LLC. The meaningful sponsors for the fund in investment in the same round are Avenir Growth Capital, Willett Advisors LLC, Noro-Moseley Partners. In the next rounds fund is usually obtained by Symbiosis, Noro-Moseley Partners, Hatteras Venture Partners.
The fund was created by Chris Shumway. Besides them, we counted 4 critical employees of this fund in our database.
Investments analytics
Analytics
- Total investments
- 11
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.92
- Follow on index
- 0.55
- Investments by industry
- Biotechnology (9)
- Medical (6)
- Pharmaceutical (4)
- Health Care (4)
- Clinical Trials (3) Show 14 more
- Investments by region
-
- United States (11)
- Peak activity year
- 2019
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 485M
- Group Appearance index
- 0.82
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Elligo Health Research | 20 Mar 2018 | Biotechnology, Health Care, Medical, Pharmaceutical | Early Stage Venture | 16M | United States, Texas, Austin |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.